BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3261594)

  • 1. In vitro immune functions in patients with minor, moderate, and severe kidney impairment.
    Langhoff E; Ladefoged J
    APMIS; 1988 Jul; 96(7):655-9. PubMed ID: 3261594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
    Langhoff E; Ladefoged J; Odum N
    Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of interleukin 2 (IL-2) production and expression of IL-2 receptors by uraemic and normal lymphocytes.
    Langhoff E; Hofmann B; Odum N; Ladefoged J; Platz P; Ryder LP; Svejgaard A
    Scand J Immunol; 1987 Jan; 25(1):29-36. PubMed ID: 3101170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E
    Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of uremic sera on the blastic transformation of lymphocytes of healthy subjects, stimulated with non-specific mitogens (PHA, con A, PWM).
    Klinger M; Kuczera J; Kruzel E
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):73-82. PubMed ID: 7416921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-mediated suppression of mitogen responses of lymphocytes in uremic patients.
    Osaki K; Otsuka H; Uomizu K; Harada R; Otsuji Y; Hashimoto S
    Nephron; 1983; 34(2):87-92. PubMed ID: 6602948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in renal failure: depression of lymphocyte transformation by uraemia and methylprednisolone. Intra-individual consistency of lymphocyte responses to the in vitro suppressive effect of steroid.
    Langhoff E; Ladefoged J
    Int Arch Allergy Appl Immunol; 1984; 74(3):241-5. PubMed ID: 6724718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of some lymphocyte functions in vitro by opioid receptor agonists and antagonist in chronic uremic patients and healthy subjects.
    Zbróg Z; Luciak M; Tchórzewski H; Pokoca L
    Int J Immunopharmacol; 1991; 13(5):475-83. PubMed ID: 1664419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
    Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH
    Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid levels and lymphocyte functions in kidney transplanted patients.
    Langhoff E; Hvidberg EF; Flachs H; Ladefoged J
    Pharmacol Toxicol; 1987 Apr; 60(4):269-73. PubMed ID: 3295838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
    Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
    Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro ozone exposure inhibits mitogen-induced lymphocyte proliferation and IL-2 production.
    Becker S; Jordan RL; Orlando GS; Koren HS
    J Toxicol Environ Health; 1989; 26(4):469-83. PubMed ID: 2785216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective radioresistant suppressor cell activity in hemodialysis patients.
    Mirapeix E; Montoliu J; Suárez C; López Pedret J; Revert L
    Nephron; 1985; 41(2):184-8. PubMed ID: 2931611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremia as a state of immune deficiency.
    Birkeland SA
    Scand J Immunol; 1976; 5(1-2):107-15. PubMed ID: 131369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen.
    Ori Y; Korzets A; Malachi T; Gafter U; Breitbart H
    J Lab Clin Med; 1999 Apr; 133(4):391-400. PubMed ID: 10218771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessory cell functions in mononuclear cell cultures uremic patients.
    Ladefoged J; Langhoff E
    Kidney Int; 1990 Jan; 37(1):126-30. PubMed ID: 2299798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired lymphocyte proliferation in human acute pancreatitis.
    Pezzilli R; Billi P; Beltrandi E; Casadei Maldini M; Mancini R
    Digestion; 1997; 58(5):431-6. PubMed ID: 9383633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.